Cyclin-dependent Kinase 5: Novel role of gene variants identified in ADHD

• Published in: Scientific reports Vol. 7; no. 1; pp. 6828 - 11
• Main Authors: Maitra, Subhamita, Chatterjee, Mahasweta, Sinha, Swagata, Mukhopadhyay, Kanchan
• Format: Journal Article
• Language: English
• Published: England Nature Publishing Group 28.07.2017; Nature Publishing Group UK; Nature Portfolio
• Subjects: Actin; Adolescent; Attention Deficit Disorder with Hyperactivity - genetics; Attention Deficit Disorder with Hyperactivity - pathology; Attention deficit hyperactivity disorder; Cell migration; Child; Cognitive ability; Cyclin-dependent kinase 5; Cyclin-Dependent Kinase 5 - genetics; Cyclin-dependent kinases; Cytoskeleton; Etiology; Female; Genotypes; Haplotypes; Humans; Impulsive behavior; Male; Morbidity; Neurotransmission; Polymorphism, Single Nucleotide; Transcription
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-017-06852-2

Cortical neuronal migration and formation of filamentous actin cytoskeleton, needed for development, normal cell growth and differentiation, are regulated by the cyclin-dependent kinase 5 (Cdk5). Attention deficit hyperactivity disorder (ADHD) is associated with delayed maturation of the brain and hence we hypothesized that cdk5 may have a role in ADHD. Eight functional CDK5 gene variants were analyzed in 848 Indo-Caucasoid individuals including 217 families with ADHD probands and 250 healthy volunteers. Only three variants, rs2069454, rs2069456 and rs2069459, predicted to affect transcription, were found to be bimorphic. Significant difference in rs2069456 "AC" genotype frequency was noticed in the probands, more specifically in the males. Family based analysis revealed over transmission of rs2069454 "C" and rs2069456 "A" to the probands. Quantitative trait analysis exhibited association of haplotypes with inattention, domain specific impulsivity, and behavioral problem, though no significant contribution was noticed on the age of onset of ADHD. Gene variants also showed significant association with cognitive function and co-morbidity. Probands having rs2069459 "TT" showed betterment during follow up. It may be inferred from this pilot study that CDK5 may affect ADHD etiology, possibly by attenuating synaptic neurotransmission and could be a useful target for therapeutic intervention.